Physician Assistant · Pittsburgh, PA
NPI
1912564774
Since 2019
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1307 Federal St Ste B300
Pittsburgh, PA, 15212
Phone (412) 359-3360
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,852
31 services
Medicare patients, 2024
22
Average age 67
Drug cost, 2024
$710K
450 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Cory J Rings prescribed most often to Medicare patients was Ampicillin-Sulbactam (Ampicillin Sod/Sulbactam Sod), with 53 prescriptions and refills. In total Cory J Rings wrote 450 Medicare prescriptions that cost $710K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 53 | 53 | Under 11 | $10K |
| Ertapenem Ertapenem Sodium | 47 | 47 | 14 | $28K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 34 | 34 | Under 11 | $130K |
| Cephalexin Generic | 27 | 27 | 15 | $211 |
| Tivicay Dolutegravir Sodium | 23 | 23 | Under 11 | $51K |
| Descovy Emtricitabine/Tenofov Alafenam | 21 | 21 | Under 11 | $47K |
| Linezolid Generic | 19 | 19 | 16 | $700 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 18 | 15 | $127 |
| Ceftriaxone Ceftriaxone Sodium | 14 | 14 | Under 11 | $573 |
| Vancomycin Hcl Generic | 12 | 12 | Under 11 | $1,411 |
| Juluca Dolutegravir/Rilpivirine | 12 | 12 | Under 11 | $40K |
| Cefazolin Sodium Generic | 12 | 12 | Under 11 | $1,328 |
| Rukobia Fostemsavir Tromethamine | 11 | 11 | Under 11 | $93K |
Brand drugs: 154 claims; generic drugs: 296 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Cory J Rings were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.